JUN and breast carcinoma: Subsequent analysis of the expression of these genes in breast cancer and corresponding normal tissues using the UACLAN and GSCA online databases was found to be consistent with the results obtained above, further suggesting the potential of TP53, ACLY, JUN, and PPARG genes to be candidate therapeutic genes.